clinical trial · NCT00655200
Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
Novo Nordisk A/S·—·completed·n = 2,286
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2insulin detemir
brief summary
This study is conducted in Asia. The aim of this observational study is to evaluate the safety and tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the treatment of Filipino patients with Type 1 and Type 2 Diabetes Mellitus.
started
Feb 1, 2008
primary completion
Sep 1, 2008
completion
Sep 1, 2008
last updated
Nov 22, 2023
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol